(3) Results: In NAFLD patients, chemokine CCL2 and FGF21 serum levels correlated with inflammatory serum markers, only CCL2 was significantly associated with advanced liver fibrosis. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatotic liver disease.